Related Experiment Video
Updated: May 27, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
How we really ought to be comparing treatments for clinical purposes
Merton S Krause1, Wolfgang Lutz
1Department of Psychology, Northwestern University.
Abstract:
Without having disaggregated clinical trial comparison groups in terms of their various different outcome-relevant sorts of cases, researchers are forced to choose treatments for subsequent individual patients on only the evidence of outcome comparisons between groups of unknown and probably unequal mixes of various differently outcome-relevant sorts of prior cases. (PsycINFO Database Record (c) 2010 APA, all rights reserved).
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Blind Procedures
Comparing the Survival Analysis of Two or More Groups
